Clinical Trials Logo

Clinical Trial Summary

PROSPECTIVE COHORT EVALUATION OF NEUROCAP® In the Treatment of symptomatic Neuroma (PROTECT Neuro)

This post-market surveillance study is conducted to provide post market surveillance information regarding long-term performance and ease of use of the Polyganics nerve capping device (NEUROCAP®) for reduction of the development of peripheral symptomatic end-neuroma.


Clinical Trial Description

1. Device description NEUROCAP®, a bioresorbable nerve capping device based upon the NEUROLAC® nerve guide, is indicated to protect a peripheral nerve end and to separate the nerve from surrounding environment to reduce the development of a symptomatic neuroma. NEUROCAP® is composed of the same biocompatible, bioresorbable copolyester composing the NEUROLAC® nerve guide, Poly(68/32[15/85 D/L] Lactide-Ԑ-Caprolactone) (PLCL).

2. Objective This post-market surveillance study is conducted to provide post market surveillance information regarding long-term performance and ease of use of the Polyganics nerve capping device (NEUROCAP®) for reduction of the development of peripheral symptomatic end-neuroma.

3. Study design This post-market surveillance study consists of a cohort study to provide post market surveillance information regarding long-term performance and ease of use of the NEUROCAP® for reduction of the development of peripheral symptomatic end-neuroma in the upper and lower extremity. Sub analyses will be performed regarding demographics and medical background. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02993276
Study type Observational
Source Polyganics BV
Contact
Status Completed
Phase
Start date April 17, 2017
Completion date August 30, 2020

See also
  Status Clinical Trial Phase
Completed NCT02930551 - Neuromas as the Cause of Pain N/A
Completed NCT00130962 - ALGRX 4975 in the Treatment of Patients With Morton's Neuroma Phase 2
Completed NCT02205385 - Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation N/A
Completed NCT02316262 - Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation N/A
Completed NCT01632709 - Pathophysiology of Post Amputation Pain Phase 4
Completed NCT02528266 - Surgical Treatment of Symptomatic Neuroma "Stop Neuroma" N/A
Withdrawn NCT01374191 - Botulinum Toxin Type A for Neuroma Pain Phase 2
Completed NCT03484429 - Postoperative Peripheral Nerve Stimulation for Management of Post-amputation Pain N/A
Completed NCT03051113 - Identification of Neuromas by High Resolution Ultrasound in Patients With Peripheral Nerve Injury and Amputations
Not yet recruiting NCT04931056 - A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.